Cargando…
Identification of 2,4-Diaminoquinazoline Derivative as a Potential Small-Molecule Inhibitor against Chikungunya and Ross River Viruses
Alphaviruses are serious zoonotic threats responsible for significant morbidity, causing arthritis or encephalitis. So far, no licensed drugs or vaccines are available to combat alphaviral infections. About 300,000 chikungunya virus (CHIKV) infections have been reported in 2023, with more than 300 d...
Autores principales: | Saha, Amrita, Acharya, Badri Narayan, Parida, Manmohan, Saxena, Nandita, Rajaiya, Jaya, Dash, Paban Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674894/ https://www.ncbi.nlm.nih.gov/pubmed/38005871 http://dx.doi.org/10.3390/v15112194 |
Ejemplares similares
-
Vector-delivered artificial miRNA effectively inhibited replication of Chikungunya virus
por: Saha, Amrita, et al.
Publicado: (2016) -
Expression and Characterization of Yeast Derived Chikungunya Virus Like Particles (CHIK-VLPs) and Its Evaluation as a Potential Vaccine Candidate
por: Saraswat, Shweta, et al.
Publicado: (2016) -
Development of nsP2 protease based cell free high throughput screening assay for evaluation of inhibitors against emerging Chikungunya virus
por: Saha, Amrita, et al.
Publicado: (2018) -
Development of a SYBR green I-based quantitative RT-PCR for Ross River virus: Application in vector competence studies and antiviral drug evaluation
por: Dash, Paban Kumar, et al.
Publicado: (2016) -
Appearance of E1: A226V mutant Chikungunya virus in Coastal Karnataka, India during 2008 outbreak
por: Santhosh, SR, et al.
Publicado: (2009)